Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 101

1.

Antitumorigenic potential of STAT3 alternative splicing modulation.

Zammarchi F, de Stanchina E, Bournazou E, Supakorndej T, Martires K, Riedel E, Corben AD, Bromberg JF, Cartegni L.

Proc Natl Acad Sci U S A. 2011 Oct 25;108(43):17779-84. doi: 10.1073/pnas.1108482108. Epub 2011 Oct 17.

2.
3.

Alternative Splicing of STAT3 Is Affected by RNA Editing.

Goldberg L, Abutbul-Amitai M, Paret G, Nevo-Caspi Y.

DNA Cell Biol. 2017 May;36(5):367-376. doi: 10.1089/dna.2016.3575. Epub 2017 Mar 9.

PMID:
28278381
4.

Reciprocal activation between PLK1 and Stat3 contributes to survival and proliferation of esophageal cancer cells.

Zhang Y, Du XL, Wang CJ, Lin DC, Ruan X, Feng YB, Huo YQ, Peng H, Cui JL, Zhang TT, Wang YQ, Zhang H, Zhan QM, Wang MR.

Gastroenterology. 2012 Mar;142(3):521-530.e3. doi: 10.1053/j.gastro.2011.11.023. Epub 2011 Nov 19.

PMID:
22108192
5.

Stat3 isoforms, alpha and beta, demonstrate distinct intracellular dynamics with prolonged nuclear retention of Stat3beta mapping to its unique C-terminal end.

Huang Y, Qiu J, Dong S, Redell MS, Poli V, Mancini MA, Tweardy DJ.

J Biol Chem. 2007 Nov 30;282(48):34958-67. Epub 2007 Sep 12.

6.

The Opposing Function of STAT3 as an Oncoprotein and Tumor Suppressor Is Dictated by the Expression Status of STAT3β in Esophageal Squamous Cell Carcinoma.

Zhang HF, Chen Y, Wu C, Wu ZY, Tweardy DJ, Alshareef A, Liao LD, Xue YJ, Wu JY, Chen B, Xu XE, Gopal K, Gupta N, Li EM, Xu LY, Lai R.

Clin Cancer Res. 2016 Feb 1;22(3):691-703. doi: 10.1158/1078-0432.CCR-15-1253. Epub 2015 Sep 24.

7.

Of alphas and betas: distinct and overlapping functions of STAT3 isoforms.

Dewilde S, Vercelli A, Chiarle R, Poli V.

Front Biosci. 2008 May 1;13:6501-14. Review.

PMID:
18508676
8.

Therapeutic effects of STAT3 decoy oligodeoxynucleotide on human lung cancer in xenograft mice.

Zhang X, Zhang J, Wang L, Wei H, Tian Z.

BMC Cancer. 2007 Aug 4;7:149.

9.

Antisense gapmers selectively suppress individual oncogenic p73 splice isoforms and inhibit tumor growth in vivo.

Emmrich S, Wang W, John K, Li W, Pützer BM.

Mol Cancer. 2009 Aug 11;8:61. doi: 10.1186/1476-4598-8-61.

10.

Stat3 and G-CSF-induced myeloid differentiation.

Chakraborty A, Tweardy DJ.

Leuk Lymphoma. 1998 Aug;30(5-6):433-42. Review.

PMID:
9711905
11.
12.

Characterization of STAT3 activation and expression in canine and human osteosarcoma.

Fossey SL, Liao AT, McCleese JK, Bear MD, Lin J, Li PK, Kisseberth WC, London CA.

BMC Cancer. 2009 Mar 10;9:81. doi: 10.1186/1471-2407-9-81.

13.

STAT3beta does not interfere with granulocyte colony-stimulating factor-induced neutrophilic differentiation.

de Koning JP, Ward AC, Caldenhoven E, de Groot RP, Löwenberg B, Touw IP.

Hematol J. 2000;1(4):220-5.

PMID:
11920194
15.

A novel missense (M206K) STAT3 mutation in diffuse large B cell lymphoma deregulates STAT3 signaling.

Hu G, Witzig TE, Gupta M.

PLoS One. 2013 Jul 4;8(7):e67851. doi: 10.1371/journal.pone.0067851. Print 2013.

16.

Stat3 activation by Src induces specific gene regulation and is required for cell transformation.

Turkson J, Bowman T, Garcia R, Caldenhoven E, De Groot RP, Jove R.

Mol Cell Biol. 1998 May;18(5):2545-52.

17.

Implication of STAT3 signaling in human colonic cancer cells during intestinal trefoil factor 3 (TFF3) -- and vascular endothelial growth factor-mediated cellular invasion and tumor growth.

Rivat C, Rodrigues S, Bruyneel E, Piétu G, Robert A, Redeuilh G, Bracke M, Gespach C, Attoub S.

Cancer Res. 2005 Jan 1;65(1):195-202. Erratum in: Cancer Res. 2005 Mar 15;65(6):2505. Christine, Rivat [corrected to Rivat, Christine]; Sylvie, Rodrigues [corrected to Rodrigues, Sylvie]; Erik, Bruyneel [corrected to Bruyneel, Erik]; Geneviéve, Piétu [corrected to Piétu, Geneviéve]; Amélie, Robert [corrected to Robert, Amélie]; Gérard, Redeuilh [corrected to Redeuilh, Gérard]; Marc, Bracke [corrected to Bracke, Marc]; Christian, Gespach [corrected to Gespach, Christian]; Samir, Attoub [corrected to Attoub, Samir].

18.

Ratios of Four STAT3 Splice Variants in Human Eosinophils and Diffuse Large B Cell Lymphoma Cells.

Turton KB, Annis DS, Rui L, Esnault S, Mosher DF.

PLoS One. 2015 May 18;10(5):e0127243. doi: 10.1371/journal.pone.0127243. eCollection 2015.

19.

STAT3beta, a splice variant of transcription factor STAT3, is a dominant negative regulator of transcription.

Caldenhoven E, van Dijk TB, Solari R, Armstrong J, Raaijmakers JA, Lammers JW, Koenderman L, de Groot RP.

J Biol Chem. 1996 May 31;271(22):13221-7.

20.

NF-kappaB/STAT3/PI3K signaling crosstalk in iMyc E mu B lymphoma.

Han SS, Yun H, Son DJ, Tompkins VS, Peng L, Chung ST, Kim JS, Park ES, Janz S.

Mol Cancer. 2010 Apr 30;9:97. doi: 10.1186/1476-4598-9-97.

Supplemental Content

Support Center